Application of the sFlt-1/PlGF Ratio in the Prediction and Management of Preeclampsia: Case Report in a High-Risk Pregnant Woman

Read full text Summarise with VIRAT
Authors: German Andres Guevara Lizarazo, Laura Juliana Posso Perea, Joshuart David Pascuas Varela, Daniela Lopez Londoño, Marbin Yulieth Alvarez Ramirez, Valentina Dehaquiz Arango
Cited by: 0
References: 10

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Preeclampsia is one of the leading causes of maternal and perinatal morbidity and mortality.Its diagnosis is based on clinical and paraclinical criteria, although in high-risk patients it can be difficult to identify at early stages.Angiogenic biomarkers, such as the sFlt-1/PlGF ratio, have emerged as highly useful complementary tools.We present the case of a 26-year-old pregnant woman with type 1 diabetes mellitus, who during the course of her pregnancy developed elevated blood pressure values and an increased sFlt-1/PlGF ratio, which guided the diagnosis of preeclampsia without severe features.Serial monitoring of biomarkers allowed close follow-up of disease progression and anticipation of its transition to severe preeclampsia, which prompted termination of pregnancy by cesarean section with favorable neonatal outcomes.The sFlt-1/PlGF ratio is a valuable diagnostic and prognostic tool in preeclampsia, especially in high-risk pregnancies.Its rational use, complemented with clinical assessment and ultrasound, optimizes decision-making and improves maternal and fetal outcomes.josha.org

Fields of Study & Subjects

Pregnancy and preeclampsia studies Neurological Complications and Syndromes Pregnancy-related medical research

Publication details

Journal / source
Journal of Science Humanities and Arts - JOSHA
Volume
13
Issue
2
Publication date
1 January 2026
Language
EN